Marimed Inc. (MRMD): Cash & Equivalents

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2014-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$7.28M
As of 2024-12-31
-37.4%
3-year compound annual growth
+58.0%
5-year compound annual growth
+22.1%
10-year compound annual growth
$29.68M2011-12-31: $118.8K2012-12-31: $8.6K2013-12-31: $8.5K2014-12-31: $988.3K2015-12-31: $160.9K2016-12-31: $569.4K2017-12-31: $1.29M2018-12-31: $4.10M2019-12-31: $738.7K2020-12-31: $3.00M2021-12-31: $29.68M2022-12-31: $9.74M2023-12-31: $14.64M2024-12-31: $7.28M$7.28M
2011-12-31 Cash & Equivalents (USD) 2024-12-31
Period endedCash & EquivalentsChange YoYSource filing
2024-12-31$7.28M-50.3%2025-03-06, Balance as of period end
2023-12-31$14.64M+50.4%2025-03-06, Balance as of period end
2022-12-31$9.74M-67.2%2024-03-07, Balance as of period end
2021-12-31$29.68M+889.7%2023-03-03, Balance as of period end
2020-12-31$3.00M+306.0%2022-03-16, Balance as of period end
2019-12-31$738.7K-82.0%2021-03-23, Balance as of period end
2018-12-31$4.10M+218.1%2020-04-01, Balance as of period end
2017-12-31$1.29M+126.6%2019-04-16, Balance as of period end
2016-12-31$569.4K+253.9%2018-04-02, Balance as of period end
2015-12-31$160.9K-83.7%2017-04-17, Balance as of period end
2014-12-31$988.3Kn/c2016-09-27, Balance as of period end
2013-12-31$8.5K-0.5%2015-06-09, Balance as of period end
2012-12-31$8.6K-92.8%2014-04-04, Balance as of period end
2011-12-31$118.8Kn/a2013-03-28, Balance as of period end